145 related articles for article (PubMed ID: 18448004)
1. [Phaeochromocytoma associated with a paraganglion syndrome].
Moreno Tejero ML; Pintor Trevejo M; Martín Ruiz C; Galán Gómez E
An Pediatr (Barc); 2008 May; 68(5):527-9. PubMed ID: 18448004
[No Abstract] [Full Text] [Related]
2. SDH-related pheochromocytoma and paraganglioma.
Kantorovich V; King KS; Pacak K
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
[TBL] [Abstract][Full Text] [Related]
3. A Guide to Pheochromocytomas and Paragangliomas.
Guilmette J; Sadow PM
Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
[TBL] [Abstract][Full Text] [Related]
5. No child left behind in SDHB testing for paragangliomas and pheochromocytomas.
Schiffman JD
J Clin Oncol; 2011 Nov; 29(31):4070-2. PubMed ID: 21969491
[No Abstract] [Full Text] [Related]
6. Germline SDHD mutation in familial phaeochromocytoma.
Astuti D; Douglas F; Lennard TW; Aligianis IA; Woodward ER; Evans DG; Eng C; Latif F; Maher ER
Lancet; 2001 Apr; 357(9263):1181-2. PubMed ID: 11323050
[TBL] [Abstract][Full Text] [Related]
7. MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma.
Dona M; Neijman K; Timmers HJLM
Int J Biochem Cell Biol; 2021 May; 134():105949. PubMed ID: 33609747
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumour in succinate dehydrogenase subunit B mutation-associated familial phaeochromocytoma/paraganglioma.
Bolland M; Benn D; Croxson M; McCall J; Shaw JF; Baillie T; Robinson B
ANZ J Surg; 2006 Aug; 76(8):763-4. PubMed ID: 16916404
[No Abstract] [Full Text] [Related]
9. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
[TBL] [Abstract][Full Text] [Related]
10. A Previously Unrecognized Monocytic Component of Pheochromocytoma and Paraganglioma.
Farhat NA; Powers JF; Shepard-Barry A; Dahia P; Pacak K; Tischler AS
Endocr Pathol; 2019 Jun; 30(2):90-95. PubMed ID: 31001800
[TBL] [Abstract][Full Text] [Related]
11. Pathology and genetics of phaeochromocytoma and paraganglioma.
Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
[TBL] [Abstract][Full Text] [Related]
12. Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.
Makis W; McCann K; McEwan AJ; Sawyer MB
Clin Nucl Med; 2016 Mar; 41(3):204-6. PubMed ID: 26359568
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
Srirangalingam U; Walker L; Khoo B; MacDonald F; Gardner D; Wilkin TJ; Skelly RH; George E; Spooner D; Monson JP; Grossman AB; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
Clin Endocrinol (Oxf); 2008 Oct; 69(4):587-96. PubMed ID: 18419787
[TBL] [Abstract][Full Text] [Related]
15. Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas.
Turchini J; Gill AJ
Am J Surg Pathol; 2020 Mar; 44(3):422-424. PubMed ID: 31789631
[No Abstract] [Full Text] [Related]
16. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
[TBL] [Abstract][Full Text] [Related]
17. Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes.
Maher ER
Clin Med (Lond); 2014 Aug; 14(4):440-4. PubMed ID: 25099851
[No Abstract] [Full Text] [Related]
18. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
Rusyn L; Kohn B
Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
[No Abstract] [Full Text] [Related]
19. Immunohistochemical Staining for SOX10 and SDHB in SDH-Deficient Paragangliomas Indicates that Sustentacular Cells Are Not Neoplastic.
Powers JF; Tischler AS
Endocr Pathol; 2020 Sep; 31(3):307-309. PubMed ID: 32562155
[No Abstract] [Full Text] [Related]
20. Modeling succinate dehydrogenase loss disorders in C. elegans through effects on hypoxia-inducible factor.
Braun MM; Damjanac T; Zhang Y; Chen C; Hu J; Maher LJ
PLoS One; 2019; 14(12):e0227033. PubMed ID: 31887185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]